|
Ulcerative Colitis
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
We found 12 SNPs tagging ten loci, including HLA-DRA, IL10, IL23R, JAK2, S100Z, ARPC2, and ECM1, to be associated with UC.
|
19861958 |
2010 |
|
Ulcerative Colitis
|
0.320 |
Biomarker
|
disease |
CTD_human |
Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility.
|
18836448 |
2008 |
|
Ulcerative Colitis
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility.
|
18836448 |
2008 |
|
Ulcerative Colitis
|
0.320 |
Biomarker
|
disease |
LHGDN |
Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility.
|
18836448 |
2008 |
|
Silicosis
|
0.200 |
Biomarker
|
disease |
RGD |
Identification of differentially expressed genes in rat silicosis model by suppression subtractive hybridization analysis.
|
18685790 |
2008 |
|
Red cell distribution width determination
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
RDW - Red blood cell distribution width result
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
Platelet Count measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
|
Platelet mean volume determination (procedure)
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
|
Platelet Component Distribution Width Measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
|
White Blood Cell Count procedure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Trans-ethnic meta-analysis of white blood cell phenotypes.
|
25096241 |
2014 |
|
Neoplasm Metastasis
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
ARPC2 also played an oncogenic role and mediated the promoting role of RBM3 in the proliferation and metastasis of human breast cancer cells.
|
30720048 |
2019 |
|
Neoplasm Metastasis
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
In addition, ARPC2 was highly associated with the tumor stage, nodal metastasis, and overall survival of patients with BrCa.
|
31002363 |
2019 |
|
Neoplasm Metastasis
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
Pimozide suppresses cancer cell migration and tumor metastasis through binding to ARPC2, a subunit of the Arp2/3 complex.
|
31571309 |
2019 |
|
Neoplasm Metastasis
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
Therefore, ARPC2 is a potential target for anti-metastatic therapy, and Benp has the clinical potential to block metastasis.
|
30710516 |
2019 |
|
Malignant neoplasm of breast
|
0.020 |
Biomarker
|
disease |
BEFREE |
In addition, ARPC2 was highly associated with the tumor stage, nodal metastasis, and overall survival of patients with BrCa.
|
31002363 |
2019 |
|
Malignant neoplasm of breast
|
0.020 |
Biomarker
|
disease |
BEFREE |
RBM3 upregulates ARPC2 by binding the 3'UTR and contributes to breast cancer progression.
|
30720048 |
2019 |
|
Malignant Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
Pimozide suppresses cancer cell migration and tumor metastasis through binding to ARPC2, a subunit of the Arp2/3 complex.
|
31571309 |
2019 |
|
Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
In addition, ARPC2 was highly associated with the tumor stage, nodal metastasis, and overall survival of patients with BrCa.
|
31002363 |
2019 |
|
Breast Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
In addition, ARPC2 was highly associated with the tumor stage, nodal metastasis, and overall survival of patients with BrCa.
|
31002363 |
2019 |
|
Breast Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
RBM3 upregulates ARPC2 by binding the 3'UTR and contributes to breast cancer progression.
|
30720048 |
2019 |
|
Tumor Cell Invasion
|
0.020 |
AlteredExpression
|
phenotype |
BEFREE |
Given that ARPC2 is critical to this progression, the present study focused on ARPC2 activity in breast cancer (BrCa) cell invasion and migration.
|
31002363 |
2019 |
|
Primary malignant neoplasm
|
0.020 |
Biomarker
|
group |
BEFREE |
Pimozide suppresses cancer cell migration and tumor metastasis through binding to ARPC2, a subunit of the Arp2/3 complex.
|
31571309 |
2019 |
|
Malignant Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
In this study, we found that ARPC2 promoted cell proliferation and invasion in the human cancer cell line MKN-28 using a cell total number assay, MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide) assay, cell colony formation assay, migration assay, invasion assay, and wound healing assay.
|
28694563 |
2017 |
|
Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
In the association analysis of 110 gastric cancer tissues, ARPC2 showed significant associations with large tumor size, lymph node invasion, and high tumor stage.
|
28694563 |
2017 |